These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30396825)

  • 21. An opioid dispensing and misuse prevention algorithm for community pharmacy practice.
    Rickles NM; Huang AL; Gunther MB; Chan WJ
    Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
    Thornton JD; Lyvers E; Scott VGG; Dwibedi N
    J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.
    Bach P; Hartung D
    Addict Sci Clin Pract; 2019 Sep; 14(1):30. PubMed ID: 31474225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives.
    Makdessi CJ; Day C; Chaar BB
    Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.
    Pollini RA; Slocum S; Ozga JE; Joyce R; Xuan Z; Green TC; Walley AY
    J Am Pharm Assoc (2003); 2022; 62(5):1546-1554. PubMed ID: 35450833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
    Skoy E; Eukel H; Werremeyer A; Strand M; Frenzel O; Steig J
    J Am Pharm Assoc (2003); 2020; 60(1):117-121. PubMed ID: 31677933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief intervention medication therapy management: Establishment of an opioid misuse intervention model delivered in a community pharmacy.
    Kenney A; Cox N; Bryan MA; Cochran G
    Am J Health Syst Pharm; 2021 Feb; 78(4):310-319. PubMed ID: 33386733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot implementation of the PharmNet naloxone program in an independent pharmacy.
    Eldridge LA; Meyerson BE; Agley J
    J Am Pharm Assoc (2003); 2023; 63(1):374-382.e12. PubMed ID: 36209035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a pharmacist-driven intervention on the outpatient dispensing of naloxone.
    Griffin S; Wishart B; Bricker K; Luebchow A
    J Am Pharm Assoc (2003); 2019; 59(4S):S161-S166. PubMed ID: 31326040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study.
    Olsen A; Lawton B; Dwyer R; Taing MW; Chun KLJ; Hollingworth S; Nielsen S
    Int J Drug Policy; 2019 Jul; 69():46-52. PubMed ID: 31078908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacists' perceptions regarding feasibility, acceptability, and usefulness of student-delivered naloxone education services in community pharmacy: A mixed methods study in Alabama.
    Hohmann L; Maxson R; McDowell L
    J Am Pharm Assoc (2003); 2023; 63(6):1731-1742.e4. PubMed ID: 37619850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Implementation-Focused Qualitative Exploration of Pharmacist Needs Regarding an Opioid Use Disorder Screening and Brief Intervention.
    Rao D; McAtee C; Mercy M; Shiyanbola OO; Ford JH
    Subst Use Addctn J; 2024 Jan; 45(1):24-32. PubMed ID: 38258852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department.
    Winstanley EL; Mashni R; Schnee S; Miller N; Mashni SM
    J Am Pharm Assoc (2003); 2017; 57(2S):S87-S91. PubMed ID: 28292506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
    Cochran G; Shen J; Cox N; Field C; Carlston K; Sengpraseut B; White A; Okifuji A; Jackman C; Haaland B; Ragsdale R; Gordon AJ; Tarter R
    Contemp Clin Trials; 2022 May; 116():106759. PubMed ID: 35417771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of a clinical tool to assess and address pain management requests in the pharmacy.
    Wood P; Tucci J; Anderson K; Mnatzaganian G
    Res Social Adm Pharm; 2019 Jul; 15(7):852-857. PubMed ID: 30611648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety.
    Cox N; Tak CR; Cochella SE; Leishman E; Gunning K
    J Am Board Fam Med; 2018; 31(1):105-112. PubMed ID: 29330245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a statewide community pharmacy approach to opioid harm reduction.
    Sexton SM; Marciniak MW; Gatton O; Shelton P
    J Am Pharm Assoc (2003); 2023; 63(1):389-395.e1. PubMed ID: 36369073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.